Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17056228> ?p ?o }
Showing triples 1 to 21 of
21
with 100 triples per page.
- Q17056228 subject Q8507014.
- Q17056228 subject Q8507345.
- Q17056228 subject Q8760205.
- Q17056228 abstract "Treatment IND or treatment investigational new drugs, is a United States regulation (made by the federal register, May 22, 1987) used to make promising new drugs available to the desperately ill patients as early in the drug development process as possible. The U.S. Food and Drug Administration (FDA) permits investigational drugs to be used under a treatment IND, if there is preliminary evidence of drug efficacy and the drug is only intended to treat a serious or life-threatening disease in their later stage of development.Few examples include such as HIV/AIDS, herpes simplex encephalitis and subarachnoid hemorrhage ,or it may be used if there is no alternative drug or therapy available to treat that degree in an intended individuals. An immediately life-threatening disease means a stage of a disease in which there is a reasonable likelihood that death will occur within a matter of months. Also in which premature death is likely without early treatment. Treatment INDs are made available to patients in need before general marketing begins, typically during phase 3 studies. Treatment INDs also allow FDA to obtain additional data on the drug's safety and effectiveness. Treatment INDs are rare; for the period of 1987-1999, only 39 such applications were approved. Of these 39 experimental treatments, 13 were allowed for cancer and 11 for HIV/AIDS. Patient advocates and healthcare activists often push for companies to apply for Treatment INDs, in hope of a new drug that may hold some promise to cure or treat a disease. There are many problems associated with this, however. Some examples include drug companies preferring controlled clinical trials over treatment INDs and patient costs, since insurance companies don't cover experimental treatments.".
- Q17056228 wikiPageExternalLink 522052?searchString=patient%20organizations.
- Q17056228 wikiPageExternalLink articleDetail.jsp?id=453246.
- Q17056228 wikiPageExternalLink 04_SB8K8xLLM9MSSzPy8xBz9CP0os3iLkCAPEzcPIwP_AH9TAyNTIxcjX2NTQ2dHM_1I_ShznPK-pvohIBMz9SNNLSwtQcxi_UgDEF2gH2lsoV-QnZhUlRqpCACSGBYo.
- Q17056228 wikiPageExternalLink InvestigationalProducts.htm.
- Q17056228 wikiPageExternalLink 517397.
- Q17056228 wikiPageWikiLink Q12199.
- Q17056228 wikiPageWikiLink Q15787.
- Q17056228 wikiPageWikiLink Q1613885.
- Q17056228 wikiPageWikiLink Q204711.
- Q17056228 wikiPageWikiLink Q30612.
- Q17056228 wikiPageWikiLink Q5440362.
- Q17056228 wikiPageWikiLink Q693442.
- Q17056228 wikiPageWikiLink Q8507014.
- Q17056228 wikiPageWikiLink Q8507345.
- Q17056228 wikiPageWikiLink Q8760205.
- Q17056228 comment "Treatment IND or treatment investigational new drugs, is a United States regulation (made by the federal register, May 22, 1987) used to make promising new drugs available to the desperately ill patients as early in the drug development process as possible. The U.S.".
- Q17056228 label "Treatment IND".